Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
810.20    -1.00 (-0.12%)
Bid:
810.20
Ask:
811.00
Spread: 0.80 (0.099%)
Market Cap: £10.18b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Market Update

20 Jan 2026 07:00

RNS Number : 5115P
Informa PLC
20 January 2026
 

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC: Market Update

20 January 2026

Growth in 2025, Compounding Growth in 2026

Market-leading brands, international reach and structural strength delivering consistent strong growth

Informa (LSE: INF.L), the international B2B Events, B2B Digital Services and Academic Markets Group, today published a Market Update, confirming strong trading through 2025, 6%± underlying revenue guidance for 2026 and £200m of new share buybacks, whilst being recognised as one of Britain's Most Admired Companies in the latest annual study sponsored by The London Stock Exchange. Separately, the Group also launched its partnership with Dubai World Trade Centre ("DWTC").

Stephen A. Carter, Group Chief Executive, Informa, said:

"2025 was a strong year for Informa and we have set ourselves the target of delivering another strong performance year in 2026."

He added: "Across the world, the Power of Live is driving strong demand for our B2B brands, whilst ongoing growth in specialist research is underpinning the strength of our academic business. First party data, AI development and international expansion continue to create new growth opportunities, including through our UAE partnership Informa International, that launches today as a separate operating business, inD."

He concluded: "Recognition in the annual study of Britain's Most Admired Companies reflects just how far Informa has come over the last 15+ years and is testament to the unwavering commitment of Colleagues, the creativity of our Partners, the consistent support of Shareholders and the progressive internationalisation of the Group."

Double-Digit Growth Confirmed in 2025

· Full Year outcome…Strong trading through Q4 2025, particularly in Live B2B Events, is expected to deliver full year results in line with or ahead of market guidance:

Double-digit growth in Revenues… Group Revenues are expected to be £4.0bn+, delivering year-on-year reported revenue growth of 12.5%+, underlying revenue growth of 6.25%± and 8%± underlying growth absent TechTarget consolidation and non-recurring LLM contracts;

Double-digit growth in Earnings…Adjusted EPS is expected to be 55.5p±, a year-on-year increase of 10.5% to 11% and 15%+ absent FX movements and non-recurring data contracts;

Growth in Free Cashflow... Adjusted Free Cashflow is expected to be £860m+, delivering further year-on-year growth and funding investment in the One Informa growth programme; Operating cash discipline remains a key focus, with ongoing scope for improving free cash flow generation.

Compounding Growth in 2026

· The Informa Growth Programme…At Informa's Capital Markets Day in November 2025, the Group committed to delivering consistent 5%+ underlying revenue growth over the next three years, faster underlying profit growth and 8%+ underlying EPS growth;

· Compounding underlying revenue growth…In 2026, we are targeting higher underlying revenue growth at 6%± (including prior year non-recurring LLM contracts and the establishment of inD), with B2B Events underlying growth of 7%+;

· Double-digit underlying earnings growth…In addition, we are targeting a sixth consecutive year of double-digit underlying adjusted earnings per share growth (excluding FX movements, biennial phasing and non-recurring LLM contracts);

· Strong 2026 visibility…Early trading supports these targets, with recurring visibility through forward booked subscriptions, exhibitor revenues and other advance contracts, delivering £1.5bn± of booked/committed revenues for 2026.

Consistent Shareholder Returns

· 2026 Share Buyback Programme…2025 Share Buyback Programme of £350m completed in December, with c.42.8m shares bought at an average share price of 817p; 2026 Share Buyback Programme launched in line with last year, with an initial minimum investment of £200m, commencing immediately, and scope for further buybacks through the year; 2025 year-end leverage is expected to be 2.4x net debt / EBITDA;

· Further dividend returns…Ongoing commitment to progressive dividends reflected in proposed 2025 ordinary dividend of 22p per share, up 10% year-on-year, which will be confirmed within the 2025 Full Year Results in March.

Conclusion

· Informa's strong performance in 2025, forward visibility and improving performance at Informa TechTarget in 2026, combined with the establishment of inD, leads to the increase in Group underlying revenue growth guidance to 6%±.

 

Enquiries

Stephen A. Carter, Group Chief Executive

+44 (0) 20 8052 0400

Gareth Wright, Group Finance Director

+44 (0) 20 8052 0400

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Tim Burt / Anthony Di Natale - Teneo

+44 (0) 7583 413254 / +44 (0) 7880 715975

 

About Britain's Most Admired Companies

Britain's Most Admired Companies is an annual study of corporate reputation run by Echo Research in partnership with the London Stock Exchange. The study recognises excellence across industry sectors, based on peer and analyst review of leading UK-listed companies. Find out more at: https://www.britainsmostadmired.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFFLLSIALIR
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 202612:14 pmRNSHolding(s) in Company
1st Jun 202610:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20262:52 pmRNSHolding(s) in Company
22nd May 20269:40 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSAnnual Financial Report and Notice of 2026 AGM
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSAppointment of inD CEO
15th Apr 20263:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:01 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:11 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 202612:32 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.